STORY · FORSKNING_
AI accelerates the design of biological drugs
MIT Technology Review documents how artificial intelligence shortens development time for biological medicines based on engineered proteins. AI reduces costs and increases success rates in the traditionally slow and resource-intensive process of drug development.
WHY IT MATTERS
This could revolutionize medical innovation by making it faster and cheaper to develop new treatments, especially for complex biological therapies that previously took years to optimize.
SOURCES
MACHINE-GENERATED SUMMARY This summary is written by machine from the sources below. We sort and explain — but we are a way into the field, not the final word. Check the source when something matters to you.